Developing a medication against skin atrophy

Trophea is addressing the medical need for an effective treatment of skin atrophy caused by long-term use of topical glucocorticoids. The project is based on an innovative combination of two well-known and studied substances that seem to offer positive synergistic efficacy on skin atrophy. Trophea’s product candidate is in preclinical phase.